K. Matsunami et al. / Phytochemistry 70 (2009) 1277–1285
1283
dient, CHCl3–MeOH (10:1, 100 mL) ? CHCl3–MeOH–H2O (15:6:1,
100 mL), 8 g fractions being collected]. Degalloylated compound
1a (1.7 mg) was recovered in fractions 10–14 as (+)-pinoresinol
(positive-ion mode) m/z: 409.1835 [M+Na]+ (Calcd. for
C19H30O8Na: 409.1832).
O-b-
D
-glucopyranoside, which was identified analysis of 1H- and
5.4.8. Catalytic hydrogenation of 19a
13C NMR spectroscopic data in C5D5N (Abe and Yamauchi, 1989)
An aliquot of 19a (1.1 mg) was dissolved in MeOH (0.5 mL),
then 1 mg of Adams’ catalyst (PtO2) was added and stirred at room
temperature for 1 h under H2 atmosphere. Hydrogenation of 19a
was monitored by TLC analysis [CHCl3: MeOH: H2O, 15:6:1, Rf val-
ues, 19a: 0.45 and dihydrodegalloylmacarangioside B (19b): 0.49].
The spot of 19b was confirmed to be identical to 3 by TLC co-chro-
matography. The reaction mixture was filtered and concentrated to
afford 19b (0.82 mg). The 1H and 13C NMR, MS and specific optical
and optical rotation value, ½a D26
ꢁ
+13.1 (c 0.11, MeOH) [Ref. for
(+)-pinoresinol O-b-D-glucopyranoside, +8.0 (c 0.1, MeOH) (Dey-
ama, 1983)]. 13C NMR (CD3OD, 150 MHz) dC: 151.2 (C-3), 149.2
(C-30), 147.6 (2 ꢂ C, C-4 & 40), 137.7 (C-1), 133.9 (C-10), 120.1 (C-
60), 119.9 (C-6), 118.3 (C-5), 116.2 (C-50), 111.9 (C-2), 111.2 (C-
20), 103.1 (C-100), 87.6 (C-70), 87.2 (C-7), 78.3 (C-300), 78.0 (C-500),
75.0 (C-200), 72.8 (2 ꢂ C, C-9 & 90), 71.5 (C-400), 62.6 (C-600), 56.9
(3-OMe), 56.6 (30-OMe), 55.6 (C-8), 55.4 (C-80).
rotation were also identical to 3 [19b: ½a D25
ꢀ8.4 (c = 0.055,
ꢁ
MeOH)].
5.4.5. Mild alkaline methanolysis of 2
In a similar to that described above, compound 2 (1.5 mg) liber-
ated degalloylated compound 2a (0.72 mg) (TLC, CHCl3: MeOH:
H2O, 15:6:1, Rf values, 2: 0.42 and 2a: 0.58). 2a: Amorphous pow-
5.4.9. NaBH4 reduction of 3a
A solution of 3a (1.62 mg) in EtOH (0.5 mL), 1.5 mg of NaBH4
dissolved in EtOH (0.5 mL) was added dropwise at 0 °C and then
stirred for 1 h at rt with the progress of the reaction was monitored
der; ½a 2D6
ꢁ
+84.2 (c 0.048, MeOH) and CD
D
e
(nm): ꢀ0.9 (311),+11.0
(244) (c 0.97 ꢂ 10ꢀ5 M, MeOH) [Ref. for (6R,9R)-3-oxo-
a
-ionol 9-O-
by TLC analysis [CHCl3: MeOH, 5:1, Rf values, 3a: 0.58, 3
a,9a-diol
b-D
-glucopyranoside; ½a D22
ꢁ
+95.2 (c 1.33, MeOH), (Mohamed et al.,
(3b): 0.49, and 3b,9 -diol (3c): 0.37]. The reaction mixture was
a
1999), CD rel.int. (nm): ꢀ8 (327), +207 (243) (EtOH) (Pabst et al.,
quenched by addition of 0.5 mL of 1% CH3COOH at 0 °C, concen-
trated and then purified by preparative TLC [CHCl3: MeOH, 5:1]
1992)].
to afford 3
3a,9a
a,9a-diol (3b) (0.64 mg) and 3b,9a-diol (3c) (0.78 mg).
5.4.6. Enzymatic hydrolysis of 3
-diol (3b): Amorphous powder; 1H NMR (CD3OD, 500 MHz)
Compound 3 (4.1 mg) was hydrolyzed with crude hesperidinase
at 37 °C in H2O (1 mL) with reciprocal shaking for 12 h. Liberation
of glucose was monitored by TLC analysis (CHCl3: MeOH: H2O,
dH: 3.99 (1H, d, J = 7 Hz, pro-R H-12), 3.97 (1H, m, H-3), 3.71 (1H,
m, H-9), 3.40 (1H, dd, J = 7, 2 Hz, pro-S H-12), 1.88–1.81 (2H, m,
H-2ax and H-4ax), 1.61–1.54 (2H, m, H-2 eq and H-4 eq), 1.54–
1.51 (3H, m, H2-8 and pro-R H-7), 1.37 (1H, m, H-6), 1.23 (3H, s,
H3-13), 1.18 (1H, m, pro-S H-7), 1.16 (3H, d, J = 6 Hz, H3-10), 0.97
(3H, s, H3-11); 1H NMR (CDCl3, 500 MHz) dH: 3.95 (1H, d, J = 8 Hz,
pro-R H-12), 3.90 (1H, m, H-3), 3.78 (1H, m, H-9), 3.47 (1H, dd,
J = 8, 2 Hz, pro-S H-12), 1.84 (1H, dd, J = 15, 5 Hz, H-4ax), 1.78
(1H, ddd, J = 15, 5, 2 Hz, H-2ax), 1.68 (1H, br d, J = 15 Hz, H-2 eq
or H-4 eq), 1.66 (1H, br d, J = 15 Hz, H-2 eq or H-4 eq), 1.56–1.49
(3H, m, H2-8 and pro-R H-7), 1.41 (1H, m, H-6), 1.27 (3H, s, H3-
13), 1.22 (3H, d, J = 6 Hz, H3-10), 1.15 (1H, m, pro-S H-7), 0.97
(3H, s, H3-11); HR-ESI-TOF-MS (positive-ion mode) m/z:
15:6:1, Rf values, 3: 0.47, aglycone 3a: 0.75, and
The reaction mixture was concentrated and subjected to silica gel
CC [7 g, = 1 cm, L = 15 cm, linear gradient, CHCl3–MeOH (10:1,
D-glucose: 0.12).
U
100 mL) ? CHCl3–MeOH–H2O (15:6:1, 100 mL) ? EtOH 30 mL,
8 g fractions were collected]. The aglycone 3a (1.8 mg, 80%) and
glucose were recovered in fractions 6–11 and 28–29, respectively.
(1S,5R,6R,9R)-megastigman-3-on-5,12-epoxy-9-ol (3a): Amor-
phous powder; ½a D24
ꢁ
+6.1 (c 0.11, MeOH) [Ref. for annuionone E:
[a]D + 4.2 (c 0.1, MeOH) (Macías et al., 2002)], IR mmax (film)
cmꢀ1: 3423, 2925, 1712, 1457, 1377, 1261, 1019; 13C NMR (CDCl3,
100 MHz) dC: 209.3 (C-3), 83.5 (C-5), 78.5 (C-12), 68.1 (C-9), 53.8
(C-6), 49.5 (C-4), 48.8 (C-2), 43.5 (C-1), 38.7 (C-8), 24.9 (C-13),
23.9 (C-10), 21.5 (C-7), 20.9 (C-11); 1H NMR (CDCl3, 400 MHz)
dH: 3.83 (1H, sextet, J = 6 Hz, H-9), 3.64 (1H, d, J = 8 Hz, pro-S H-
12), 3.58 (1H, dd, J = 8, 2 Hz, pro-R H-12), 2.42–2.32 (3H, over-
251.1614 [M + Na]+ (Calcd. for C13H24O3Na: 251.1617). 3b,9
a-diol
(3c): Amorphous powder; [
a
]
D
24 + 18.5 (c 0.052, MeOH); 1H NMR
(CD3OD, 500 MHz) dH: 3.95 (1H, tt, J = 10, 7 Hz, H-3), 3.62 (1H, d,
J = 8 Hz, pro-R H-12), 3.73 (1H, sextet, J = 6 Hz, H-9), 3.42 (1H, dd,
J = 8, 2 Hz, pro-S H-12), 1.80 (1H, m, H-4ax), 1.66 (1H, m, pro-R
H-7), 1.64 (1H, m, H-2ax), 1.54 (2H, m, H2-8), 1.46 (2H, m, H-
2 eq and H-4 eq), 1.35 (1H, m, H-6), 1.32 (1H, m, pro-S H-7), 1.23
(3H, s, H3-13), 1.18 (3H, d, J = 6 Hz, H3-10), 1.00 (3H, s, H3-11);
HR-ESI-TOF-MS (positive-ion mode) m/z: 251.1616 [M+Na]+
(Calcd. for C13H24O3Na: 251.1617).
lapped, H-2b, 4
a and 4b), 2.23 (1H, dt, J = 18, 2 Hz, H-2a), 1.74
(1H, dq, J = 16, 6 Hz, pro-R H-7), 1.68 (1H, m, H-6), 1.63 (2H, q,
J = 6 Hz, H2-8), 1.37 (1H, dq, J = 16, 6 Hz, pro-S H-7), 1.33 (3H, s,
H3-13), 1.24 (3H, d, J = 6 Hz, H3-10), 1.08 (3H, s, H3-11); CD
De
(nm): +0.04 (357), ꢀ0.25 (281), ꢀ0.70 (211) (c = 4.78 ꢂ 10ꢀ5 M,
MeOH); HR-ESI-TOF-MS (positive-ion mode) m/z: 249.1464
[M+Na]+ (Calcd. for C13H22O3Na: 249.1461).
5.4.10. Preparation of (S)- and (R)-MTPA diesters (3d and 3e) from 3c
A solution of 3c (0.39 mg) in dry CH2Cl2 (0.5 mL) was reacted
with (S)-MTPA (14.3 mg) in the presence of 1-ethyl-3-(3-dimethyl-
aminopropyl) carbodiimide hydrochloride (EDC) (7.7 mg) and 4-
N,N’-dimethylaminopyridine (DMAP) (5.7 mg), and stirred at
25 °C for 30 min, then 40 °C for 5 min. After addition of H2O
(0.5 mL) and CHCl3 (0.5 mL) the solution was successively washed
with 1 M HCl (1 mL), NaHCO3-saturated H2O (1 mL), and saturated
brine (1 mL). The organic layer was dried (Na2SO4), and evaporated
under reduced pressure. The resulting residue was then purified by
preparative TLC (silica gel (0.25 mm thickness, applied for 18 cm
and developed with CHCl3–(CH3)2CO (20: 1) for 9 cm and eluted
with CHCl3–MeOH (2:1)) to furnish a diester, 3d (0.7 mg, 66%).
Through a similar procedure, 3e (0.8 mg, 75%) was also prepared
from 3c (0.39 mg) using (R)-MTPA (10.3 mg), EDC (7.9 mg) and
DMAP (3.9 mg). (1S,3S,5R,6R,9R)-megastigman-5,12-epoxy-3,9-
diol 3,9-di-(S)-MTPA ester (3d): Amorphous powder; 1H NMR
The absolute configuration of glucose was determined to be
D
by the sign of its positive optical rotation and retention time
(14.8 min) following HPLC separation [JASCO OR-2090 plus: Opti-
cal rotation detector, SHODEX Asahipak NH2P-50:
L = 25 cm, 80% CH3CN aq., 1 mL/min]. Peaks were identified by
co-chromatography with authentic -glucose.
U = 4.5 mm,
D
5.4.7. Mild alkaline methanolysis of macarangioside B (19)
In a similar manner to that described above, compound 19
(2.0 mg) liberated degalloylated compound 19a (1.2 mg) (TLC,
CHCl3: MeOH: H2O, 15:6:1, Rf values, 19: 0.25 and 19a: 0.51). Deg-
alloylmacarangioside B (19a): Amorphous powder; ½a D24
ꢀ29.5
ꢁ
(c = 0.078, MeOH); IR mmax (film) cmꢀ1: 3395, 2925, 1712, 1652,
1455, 1266, 1072, 1037; 13C NMR (CD3OD): Table 2; 1H NMR
(CD3OD): Table 3; CD
D
e
(nm): +0.33 (354), ꢀ0.72 (284), +0.62
(243), ꢀ0.73 (211) (c = 2.02 ꢂ 10ꢀ5 M, MeOH); HR-ESI-TOF-MS